Automation of serum (1→3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia.
about
Emerging issues with diagnosis and management of fungal infections in solid organ transplant recipientsPerformance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.Serum and bal beta-D-glucan for the diagnosis of Pneumocystis pneumonia in HIV positive patients.Characterisation of Candida within the Mycobiome/Microbiome of the Lower Respiratory Tract of ICU PatientsChemotherapy-Induced Intestinal Mucosal Barrier Damage: a Cause of Falsely Elevated Serum 1,3-Beta-d-Glucan Levels?(1→3)-β-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy: A Cohort StudyDetection of (1→3)-β-d-Glucan in Eumycetoma Patients.(1→3)-β-d-Glucan: A Biomarker for Microbial Translocation in Individuals with Acute or Early HIV Infection?Reliability of serum 1,3-beta-D-glucan assay in patients undergoing renal replacement therapy: a review of the literature.Our 2015 approach to invasive pulmonary aspergillosis.Invasive candidiasis: future directions in non-culture based diagnosis.Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status.Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery.Detection of (1→3)-β-D-glucan in same-day urine and serum samples obtained from patients with haematological malignancies.Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation.[Aspergillus in airway material : Ignore or treat?]Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.Correlation of (1→3)-β-D-glucan with other inflammation markers in chronically HIV infected persons on suppressive antiretroviral therapy.Treatment of Aspergillosis
P2860
Q28084643-94C23B34-152E-4266-B76C-93FF55985338Q33703531-90D331F6-77D6-45E4-BC51-D62C084D17BBQ34979600-6A96E9B3-7F26-4173-982F-DDC2E5E47F38Q36024184-F41B17C2-6098-416A-94F7-25EFB23A1980Q36620865-B3D9C0E9-C94F-4B39-A015-7AB351CC8626Q36822948-90936C78-854B-4B9C-B419-406F15CE933EQ37280625-D7B88A43-FDEA-4746-809F-1616789F24CBQ37304283-22602E6B-FBC8-41E6-8827-A32A56AB97D6Q38262058-279EA684-490E-4371-AEC5-3D6BC51CA8E6Q38391049-0F828821-EE23-4459-B0C0-2215FDCC9EC9Q38614492-6834BD3B-E093-4123-9216-FFD0C993BF7FQ39062930-69D45CEF-B289-4DA7-B882-62D2E8576F0AQ39367515-89E44C2A-4BC1-4CAD-90F2-F104A37658CCQ39367519-0D764D5B-EBD3-468D-ACF4-55B2AB09D165Q39377751-395451EC-146E-4C8F-967B-621D23F94961Q39391519-78882517-14B1-4DAD-A7F6-4D9BD9B54D21Q49546197-4BCC3F7B-F1F6-4676-B7B6-F58FD4919259Q50072321-B066B3F9-D39D-4946-BAC8-E0594C8E0D8DQ51159025-161A9F91-187D-4DE5-A12A-6D3F76E7EC42Q58765898-A7DBA4D2-848D-43E3-B389-E0F9A9A82025
P2860
Automation of serum (1→3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Automation of serum (1→3)-beta ...... s with and without candidemia.
@en
Automation of serum
@nl
type
label
Automation of serum (1→3)-beta ...... s with and without candidemia.
@en
Automation of serum
@nl
prefLabel
Automation of serum (1→3)-beta ...... s with and without candidemia.
@en
Automation of serum
@nl
P2093
P2860
P356
P1433
P1476
Automation of serum (1→3)-beta ...... ts with and without candidemia
@en
P2093
Harald H Kessler
Jasmin Wagner
Martie Truschnig-Wilders
Reinhard B Raggam
Robert Krause
P2860
P304
P356
10.1093/MMY/MYU023
P577
2014-06-06T00:00:00Z